OxyFile #409
LifeTECH Scientists to Present Four Abstracts on Blood Sterilization to The 3rd Annual Meeting of The Oxygen Society TORONTO, Nov. 19 1996 /CNW/ - LifeTECH Corporation today announced that the prestigious Oxygen Society has accepted four scientific abstracts by LifeTECH scientists for presentation at the 3rd Annual Meeting of the Oxygen Society in Miami, Florida from November 21-25, 1996. In making the announcement, Dr. Peter Lea, LifeTECH's Director of Research and Development said: "This reaffirms that LifeTECH has gained the attention of the international scientific community. Our leading edge research into inactivation of viruses in blood is now receiving the scientific attention it deserves. Over the last seven months, a total of ten abstracts describing our innovative research and development have been peer-reviewed and accepted by prestigious international scientific bodies, indicating their appreciation of the rigorous scientific analysis that we are bringing to the area of viral inactivation through oxidative stress (ozone). Our attendance at future scientific conferences will highlight and further validate our continuing scientific success." Mr. Walter Dermott, LifeTECH's President and CEO added: "No other technology can achieve the inactivation of enveloped and non- enveloped viruses and bacteria that the Sterinetics System achieves. LifeTECH is now positioned to become the global market leader in biofluid sterilization." The LifeTECH scientists will present data on the inactivation of both enveloped and non-enveloped viruses using the Corporation's patented Sterinetics System. Specific abstracts will focus on viral inactivation in human immunoglobulin, the effects of ozonation on human intravenous immunoglobulin, and the effect of oxidative stress on human endothelial cells. The Oxygen Society is an international society of scientists dedicated to the knowledge and understanding of the chemistry, biology, and pathology of oxygen and its metabolites, related free radicals, other activated or reactive species, and antioxidants. A constituent member of the International Society for Free Radical Research, the Oxygen Society has over 850 members in North and South America, primarily scientists and physicians interested in free radical and antioxidant biology. LifeTECH Corporation is a Canadian biotechnology company dedicated to developing and commercializing innovative technologies to sterilize blood and other biological fluids. LifeTECH's Sterinetics System is designed to inactivate viruses and bacteria in the global blood supply, including the HIV and Hepatitis viruses. LifeTECH common shares (LFTK) and warrants (LFTK.WT) trade on the Canadian Dealing Network. From Canada Newswire